Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)

PHASE3CompletedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

June 2, 2020

Study Completion Date

June 2, 2020

Conditions
Immune Thrombocytopenic Purpura
Interventions
DRUG

Fostamatinib Disodium

Fostamatinib Disodium tablet 100 mg or 150 mg by mouth twice a day

Trial Locations (55)

1140

Hanusch-Krankenhaus Wiener Gebietskrankenkasse, Vienna

1431

UMHAT Aleksandrovska, EAD, Sofia

1714

Sykehuset Østfold Kalnes, Grålum

1756

Specialized Hospital for Active Treatment of Hematology Diseases, EAD, Sofia, Department of Chemotherapy, Hemotherapy and Blood Inherited Diseases to Clinic of Clinical Hematology;, Sofia

2031

Prince of Wales Hospital, Randwick

2139

Concord Repatriation General Hospital, Concord

2145

Westmead Hospital, Westmead

2170

Liverpool Hospital, Liverpool

2730

Herlev Hospital, Herlev

3000

MHAT Hristo Botev, AD, Vratsa, First Internal Department, Vratsa

3004

The Alfred, Melbourne

5021

Haukeland universitetssykehus, Helse Bergen HF, Bergen

5800

UMHAT Dr. Georgi Stranski, EAD, Pleven, Clinic of Hematology, Pleven

6009

Perth Blood Institute, Nedlands

7250

Launceston General Hospital, Launceston

10065

Weill Cornell Medical College/New York Presbyterian Hospital, New York

Weill Cornell Medicine, New York

20817

Center for Cancer and Blood Disorders, Bethesda

27834

East Carolina University, Brody School of Medicine, Greenville

28046

Hospital Universitario La Paz, Madrid

28144

"W.G. Bill Hefner VA Medical Center", Salisbury

33100

"Azienda Ospedaliero-Universitaria Santa Maria della Misericordia - Clinica Ematologica", Udine

40138

"Istituto di Ematologia Lorenzo e Ariosto Seràgnoli", Bologna

45042

Signal Point Clinical Research Center LLC, Middletown

46026

Hospital Universitari i Politécnic La Fe de Valencia, Valencia

47905

Horizon Oncology Research, Inc, Lafayette

61615

Bleeding & Clotting Disorders Institute, Peoria

85710

Arizona Oncology Associates, Tucson

L8N 3Z5

Hamilton Health Sciences Corporation, Hamilton

M5B1W8

St. Michael's Hospital, Toronto

625 00

Fakultni nemocnice Brno, Brno

708 52

Fakultni nemocnice Ostrava, Ostrava-Poruba

H-7624

Pecsi Tudomanyegyetem Klinikai Kozpont, I. sz. Belgyogyaszati Klinika, Pécs

2545 CH

HAGA ziekenhuis, The Hague

50-367

Samodzielny Publiczny Szpital Kliniczny Nr 1 we Wrocrlaw, Wroclaw

76-200

Wojewodzki Szpital Specjalistyczny im. J. Korczaka, Słupsk

80-952

Lkinika Hematologii I Transplantologii Uniwersyteckie Centrum Kliniczne, Gdansk

31-501

SPZOZ Szpital Uniwersytecki w Krakowie Pracownia Separacji Krwinek i Bank Komórek Krwiotwórczych Klinika Hematologii, Krakow

93-510

Wojewódzki Szpital Specjalistyczny im. M. Kopernika w Łodzi, Lodz

20-601

Specjalistyczny Gabinet Lekarski, Lublin

45-061

Szpital Wojewodzki w Opolu, Opole

02-776

Instytut Hematologii I Transfuzjologii, Warsaw

020125

Spitalul Clinic Colentina, Hematologie, Bucharest

08035

Hospital Universitari Vall d'Hebron, Barcelona

CO4 5JL

Colchester General Hospital, Colchester

NE1 4LP

Royal Victoria Infirmary, Newcastle upon Tyne

CT1 3NG

Kent & Canterbury Hospital, Canterbury

NR31 6LA

James Paget University Hospital, Great Yarmouth

LS9 7TF

St. James's Hospital, Leeds

LE1 5WW

Leicester Royal Infirmary, Leicester

L78XP

Royal Liverpool University Hospital, Liverpool

W12 0HS

Imperial College Healthcare NHS Trust, London

WC1E 6AG

University College Hospital, London

OX3 7LE

Cancer and Haematology Centre, Oxford

ST4 6QG

University Hospital of North Midlands NHS Trust, Royal Stoke University Hospital, Stoke-on-Trent

Sponsors
All Listed Sponsors
lead

Rigel Pharmaceuticals

INDUSTRY